Table: Hisamitsu -Q1 group results

Hisamitsu Pharmaceutical Co

10/07/2025 07:30

Jul 10 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2025        May 31, 2024     Feb 28, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               34.67               35.81           165.00    
                   (-3.2 pct)          (+11.6 pct)      (+5.8 pct)  
  Operating            3.36                4.15            20.00    
                   (-18.9 pct)         (-4.9 pct)       (+5.8 pct)  
  Recurring            3.78                5.56            24.30    
                   (-32.0 pct)         (-2.7 pct)       (+1.2 pct)  
  Net                  2.56                4.79            22.00    
                   (-46.4 pct)         (+18.2 pct)      (+1.1 pct)  
  EPS               35.14 yen           63.89 yen       301.45 yen  
  EPS Diluted       35.10 yen           63.82 yen                   
  Ann Div                               90.00 yen       120.00 yen  
  -Q2 div                               45.00 yen        60.00 yen  
  -Q4 div                               45.00 yen        60.00 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T